Citizens Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.5M Buy
210,648
+3,848
+2% +$897K 0.64% 31
2026
Q1
$50.5M Buy
206,800
+7,966
+4% +$1.86M 0.7% 27
2025
Q4
$41.1M Buy
198,834
+3,369
+2% +$666K 0.55% 36
2025
Q3
$36.2M Buy
195,465
+31,130
+19% +$5.33M 0.5% 42
2025
Q2
$25.1M Buy
164,335
+11,624
+8% +$1.79M 0.4% 48
2025
Q1
$25.3M Sell
152,711
-4,867
-3% -$762K 0.5% 40
2024
Q4
$22.8M Sell
157,578
-16,883
-10% -$2.62M 0.44% 48
2024
Q3
$28.3M Sell
174,461
-6,040
-3% -$962K 0.57% 33
2024
Q2
$26.4M Buy
180,501
+81,780
+83% +$12.2M 0.59% 33
2024
Q1
$15.6M Sell
98,721
-8,868
-8% -$1.41M 0.52% 40
2023
Q4
$16.9M Buy
107,589
+4,954
+5% +$760K 0.58% 34
2023
Q3
$16M Sell
102,635
-25,247
-20% -$4.17M 0.65% 32
2023
Q2
$21.2M Sell
127,882
-7,128
-5% -$1.15M 0.77% 27
2023
Q1
$20.9M Buy
135,010
+53,387
+65% +$8.62M 0.77% 25
2022
Q4
$14.4M Sell
81,623
-831
-1% -$143K 0.56% 37
2022
Q3
$13.5M Sell
82,454
-602
-0.7% -$102K 0.6% 34
2022
Q2
$14.7M Sell
83,056
-4,410
-5% -$786K 0.62% 36
2022
Q1
$15.5M Sell
87,466
-5,132
-6% -$873K 0.54% 43
2021
Q4
$15.4M Buy
92,598
+742
+0.8% +$121K 0.52% 49
2021
Q3
$14.8M Buy
91,856
+4,921
+6% +$840K 0.55% 44
2021
Q2
$14.3M Buy
86,935
+4,277
+5% +$708K 0.62% 41
2021
Q1
$13.6M Buy
82,658
+7,109
+9% +$1.15M 0.72% 40
2020
Q4
$11.9M Sell
75,549
-66,085
-47% -$9.75M 0.68% 43
2020
Q3
$21.1M Sell
141,634
-6,745
-5% -$998K 1.35% 16
2020
Q2
$20.9M Sell
148,379
-1,138
-0.8% -$166K 1.46% 14
2020
Q1
$19.6M Buy
149,517
+9,227
+7% +$1.31M 1.6% 12
2019
Q4
$20.5M Sell
140,290
-1,267
-0.9% -$172K 1.37% 13
2019
Q3
$18.3M Sell
141,557
-3,124
-2% -$412K 1.32% 12
2019
Q2
$20.2M Sell
144,681
-3,070
-2% -$425K 1.48% 12
2019
Q1
$20.7M Buy
147,751
+1,441
+1% +$193K 1.52% 11
2018
Q4
$18.9M Sell
146,310
-867
-0.6% -$121K 1.72% 11
2018
Q3
$20.3M Sell
147,177
-4,645
-3% -$617K 1.6% 13
2018
Q2
$18.4M Sell
151,822
-3,358
-2% -$419K 1.54% 14
2018
Q1
$19.9M Sell
155,180
-9,080
-6% -$1.23M 1.67% 12
2017
Q4
$23M Sell
164,260
-671
-0.4% -$93.5K 1.85% 9
2017
Q3
$21.4M Sell
164,931
-449
-0.3% -$59.5K 1.83% 9
2017
Q2
$21.9M Sell
165,380
-5,034
-3% -$642K 1.93% 8
2017
Q1
$21.2M Buy
170,414
+3,578
+2% +$427K 1.88% 9
2016
Q4
$19.2M Sell
166,836
-9,002
-5% -$1.04M 1.86% 9
2016
Q3
$20.8M Sell
175,838
-1,581
-0.9% -$192K 1.97% 8
2016
Q2
$21.5M Buy
177,419
+13,504
+8% +$1.53M 2.07% 7
2016
Q1
$17.7M Buy
163,915
+4,335
+3% +$449K 1.7% 9
2015
Q4
$17.3M Buy
+159,580
New +$16M 1.65% 9

Other funds holding JNJ

Citizens Financial Group's JNJ Position: Q2 2026 in Review

Citizens Financial Group increased its Johnson & Johnson (JNJ) stake by 1.9% in Q2 2026, buying an estimated $897K and bringing the position to 210,648 shares worth $53.5M. The position accounts for 0.64% of the portfolio, ranked #31.

Citizens Financial Group first reported a position in JNJ in Q4 2015 and has held it in 43 quarters since. 3,472 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Citizens Financial Group held 210,648 shares of Johnson & Johnson worth $53.5M as of Q2 2026.
  • Citizens Financial Group bought 3,848 Johnson & Johnson shares in Q2 2026, an estimated $897K.
  • Johnson & Johnson made up 0.64% of Citizens Financial Group's portfolio in Q2 2026, its #31 holding.
  • Citizens Financial Group first reported a position in Johnson & Johnson in Q4 2015 and has held it in 43 quarters since.
  • 3,472 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.